Risk factors like HIV‐1‐non‐B subtype [4], high HIV‐load and low CD4 cell count [3], insufficient adherence and co‐infections influencing the drug levels can possibly facilitate the selection of DTG‐resistant variants, in our case the R263K and the G118R substitutions. Here, CD4 is linked to coinfection.